Active — Not RecruitingNot Applicable

Hyperbaric Oxygen Therapy Used on Severely Injured Healthy Individuals With Fungal Infections

Israel7 participantsStarted 2024-08-04

Plain-language summary

The goal of this observational study is to learn about the effects of Hyperbaric Oxygen Therapy on healthy individual who suffer from invasive fungal infection caused by severe trauma, who do not respond to conventional treatment. The main question it aims to answer is: Does the treatment aid in eradicating the infection and improve the overall outcome of such patients?

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * at least 18 year old * Trauma as the insult type causing the infection * Refractory IFI with failure to respond to standard therapy (medical and surgical) * Hyperbaric Oxygen Therapy as part of the treatment Exclusion Criteria: * Patients who did not recieve hyperbaric oxygen therapy as part of the treatment * Patients with immunosuppression background

What they're measuring

Eradication of Fungal Infectious Agent

Timeframe: From enrollment, baseline day 1, through study completion, an average of 4-8 weeks

Trial details

NCT IDNCT07120581

SponsorAssaf-Harofeh Medical Center

Sponsor typeOTHER_GOV

Study typeOBSERVATIONAL

Primary completion2025-12

View on ClinicalTrials.gov More Invasive Fungal Infections trials